Corporate Banner
Satellite Banner
RNAi
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

BD Announces Approval of Safety Integrated IV Catheter System for Subcutaneous Therapy in Europe

Published: Tuesday, July 23, 2013
Last Updated: Tuesday, July 23, 2013
Bookmark and Share
BD Saf-T-Intima™ increases patient comfort and in-dwell times while enabling cost savings and reducing the risk of sharps injuries and infection.

BD (Becton, Dickinson and Company), a leading global medical technology company, announces the approval of the BD Saf-T-Intima™ Safety Integrated IV Catheter System for use in subcutaneous infusion therapies in Europe.

Subcutaneous infusion is increasingly and widely used for therapies such as rehydration, post-operative pain management, palliative care and paediatric care. It provides an affordable, effective, and less invasive alternative to the established intravenous route. Subcutaneous infusion also offers the benefit of many subcutaneous sites, rather than limited intravenous sites, which helps to increase patient comfort.

This will particularly benefit elderly care as one of the top ten most common reasons for the elderly being admitted to hospital is dehydration. The National Patient Safety Agency, Royal College of Nursing and Water UK have acknowledged lack of hydration as a significant problem in hospitals as it increases hospital stays and is linked to a number of serious conditions such as coronary heart disease and stroke. Dehydration is placing an economic burden of an estimated $1 billion on healthcare systems, but proper hydration alone could save the NHS £0.95 billion by reducing associated illnesses and bed days. This is particularly pertinent in light of the recent Lords Committee Report highlighting the need for changes to healthcare, amongst other areas, to help an increasingly ageing society sustain a good quality of life.

Andrew Jackson, IV Nurse Consultant and owner of IVTEAM.com, who has written a report which reviews subcutaneous infusion therapy[vi], comments: “Subcutaneous infusion therapy is increasingly being adopted by healthcare organisations. It is a clinically safe and cost effective approach to large volume fluid replacement, and its growth will not be limited to the hospital setting. The development of care in the home and the prevention of expensive hospital admissions will ensure this form of therapy benefits patients in a variety of clinical settings. Problems associated with the intravenous route, such as device related bacteraemia, are reduced, and staff and patients alike benefit from its ease of use, potential for increased dwell time, and the number of anatomical sites available. A quality device will ensure patients and clinicians enjoy all the benefits of subcutaneous infusion therapy.”

BD Saf-T-Intima™ is approved by the British Standards Institution and includes all the characteristics of the most suitable devices for subcutaneous access, such as comfortable wings for stability and support, and an integral short extension tube to aid smooth insertion and reduce catheter movement during use. The pre-attached extension line reduces additional cost in assembly time, and reduces touch contamination risk. An increase to in-dwell times reduces overall costs of the therapy implemented, as well as in catheter materials, and staff time.

Clinicians and others are safeguarded from potential sharps injuries and infection as the patented shielding design incorporates a telescoping needle shield that passively covers the stylet as it is withdrawn from the catheter.  Patients benefit from a reduced infection risk as the subcutaneous route does not interact with the main blood vessels.

BD Vialon™ biomaterial is used to manufacture the BD Saf-T-Intima™. The Vialon softening capabilities avoid kinking issues and lead to a more comfortable cannula experience for the patient compared to steel wing needle alternatives. The material can permit longer cannulation with less risk of complication while also helping to ensure subcutaneous infusion in-dwell times. BD Saf-T-Intima is DEHP free.

A useful tool available to all is BD’s Europe-wide safety website which provides an overview of BD’s healthcare worker safety programme which takes a holistic approach to safety.  Health economics, risk assessment, conversion management and training are all crucial elements.  The site also includes an overview of BD’s range of safety-engineered medical devices.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More than 4,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Liquid Biopsies: Miracle Diagnostic or Next New Fad?
Thanks to the development of highly specific gene-amplification and sequencing technologies liquid biopsies access more biomarkers relevant to more cancers than ever before.
Cancer Gene-Drug Combinations Ripe for Precision Medicine
The study aims to expand the number of cancer gene mutations that can be paired with a precision therapy.
Exploiting Malaria’s Achilles’ Heel
Researchers have uncovered an Achilles' heel in malaria's anti-drug treatment arsenal that could lead to a disease cure.
Targeting BRAF Mutations in Thyroid Cancer
Treating metastatic thyroid cancer patients harboring a BRAF mutation with vemurafenib showed anti-tumor activity in a third of patients.
Colon Cancer Blocked in Mice
Case Western Reserve University Researchers block common type of colon cancer tumour in mice, laying groundwork for human clinical trial.
Protein Nanocages Could Improve Drug Design and Delivery
HHMI scientists have designed and built 10 large protein icosahedra that are similar to viral capsids that carry viral DNA.
Cancer Related Immune Response Genes Uncovered
Researchers at the SBP have identified over 100 new genetic regions that affect the immune response to cancer.
New Therapeutic Targets For Small Cell Lung Cancer Identified
Researchers at UTSW Medical Center have identified a protein termed ASCL1 that is essential to the development of small cell lung cancer.
Liquid Biopsies Treating Ovarian Cancer
Researchers have discovered a promising monitor and treat recurrence of ovarian cancer. Detecting cancer long before tumours reappear.
Virus Inspired Cell Cargo Ships
Virus-inspired container design may lead to cell cargo ships following construction of ten large, two-component, icosahedral protein complexes.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!